期刊文献+

肾康丸对糖尿病肾病大鼠TGF-β1/Smad信号通路的影响 被引量:17

Effect of Shenkangwan on TGF-β1/Smad signaling pathway in rat diabetic nephropathy
下载PDF
导出
摘要 目的探讨肾康丸对糖尿病肾病(diabetic nephropathy,DN)大鼠TGF-β1/Smad信号通路影响。方法用链脲佐菌素(STZ)腹腔注射法诱导建立大鼠糖尿病(diabetes mellitus,DM)模型,模型成功后随机分为3组:模型对照组、开搏通组、肾康丸组,另设正常对照组,治疗8周后,取大鼠肾脏,采用逆转录聚合酶链反应(RT-PCR)法观察各组大鼠肾脏组织纤连蛋白(fibronetin,FN)和TGF-β1mRNA基因表达情况;采用免疫组化法观察各组大鼠肾脏组织Smad2、Smad3蛋白表达的情况。结果在治疗的8周里,模型组大鼠血糖均维持在16.7mmol/L以上;出现多饮、多食、多尿、消瘦的DM症状;8周后,DN模型组大鼠与正常大鼠比较,肾脏组织中FN和TGF-β1mRNA基因表达显著上调(P<0.01),Smad2、Smad3蛋白表达明显增加。肾康丸和开搏通都可以抑制DN大鼠肾脏组织中FN和TGF-β1mRNA基因表达,差异具有统计学意义(P<0.01),都可以减少Smad2、Smad3蛋白的表达。结论肾康丸可以抑制DN大鼠肾脏中TGF-β1/Smad信号转导通路的激活,减少细胞外基质合成和分泌,从而延缓DN进程。 Objective To explore the mechanism of Shenkangwan in preventing the development of diabetic nephropathy (DN) through TGF-β1/Smad signaling pathway. Methods The diabetic rat models were established by intraperitoneal injection of streptozotocin (STZ) in male Wistar rats and randomly divided into 3 groups: model control group, Capoten group and Shenkangwan group. Another 8 normal Wistar rats served as normal control. After the rats had been treated for 8 weeks, the mRNA expressions of fibronetin (FN) and TGF-β1 were detected by RT-PCR and the protein expressions of Smad 2, Smad 3 by immunohistochemistry in the renal tissues. Results During the past 8 weeks, the blood glucose of the rats in the model control group was all over 16.7 mmol/L and they exhibited the symptoms of diabetes mellitus, such as excessive thirsty, extreme hunger, frequent urination and unusual weight loss. The mRNA expressions of FN and TGF-β1 in rat renal tissues of model control group were significantly higher than those in the rats of normal control group (P 〈 0.01 ), accompanied by the increased quantity of the cells positive of Smad 2 and Smad 3 in their kidneys. Compared with model control group, the mRNA expressions of FN and TGF-β1 as well as the protein expres- sions of Smad 2 and Smad 3 in the rat kidney tissues of Shenkangwan and capoten groups were significantly decreased (P 〈0. 01 ). Conclusion Shenkangwan can restrain the activation of TGF-β1/Smad signaling pathway and reduce the synthesis and secretion of extracellular matrix in the renal tissues of DN rats, which would conduce to postphone the development of DN.
作者 肖炜 马云
出处 《第三军医大学学报》 CAS CSCD 北大核心 2008年第16期1564-1567,共4页 Journal of Third Military Medical University
基金 广东省自然科学基金(7300233)~~
关键词 肾康丸 糖尿病肾病 TGF-Β1/SMAD信号通路 Shenkangwan diabetic nephropathy TGF-β1/Smad signaling pathway
  • 相关文献

参考文献8

  • 1Giunti S, Barit D, Cooper M E. Diabetic nephropathy: from mechanisms to rational therapies[ J ]. Minerva Med, 2006, 97 ( 3 ) : 241 - 262.
  • 2陈国宝,魏连波,龙海波.肾康丸治疗早期糖尿病肾病的临床研究[J].浙江中医杂志,2006,41(5):260-261. 被引量:17
  • 3肖炜,魏连波,马云,龙海波,陈国宝.肾康丸对糖尿病大鼠肾脏保护作用的实验研究[J].中国中药杂志,2006,31(12):1006-1009. 被引量:9
  • 4Kanwar Y S, Wada J, Sun L, et al. Diabetic nephropathy: mechanisms of renal disease progression [ J ]. Exp Biol Med, 2008, 233 ( 1 ): 4 -11.
  • 5肖炜,马云,魏连波.TGF-β/Smads信号通路与糖尿病肾病[J].国外医学(泌尿系统分册),2005,25(5):676-680. 被引量:9
  • 6Furuse Y, Hashimoto N, Maekawa M, et al. Activation of the Smad pathway in glomeruli from a spontaneously diabetic rat model, OLETF rats[J]. Nephron Exp Nephrol, 2004, 98(3): e100- 108.
  • 7Okazaki Y, Yamasaki Y, Uchida H A,et al. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the ATla receptor[J]. Clin Exp Nephrol, 2007, 11 ( 1 ) : 77 -87.
  • 8Kim H W, Kim B C, Song C Y, et al. Heterozygous mice for TGF-betalIR gene are resistant to the progression of streptozotocin-induced diabetic nephropathy[J]. Kidney lnt, 2004, 66(5): 1859- 1865.

二级参考文献41

  • 1苗明三,孙艳红.玉米须总皂苷降糖作用研究[J].中国中药杂志,2004,29(7):711-712. 被引量:77
  • 2朱雪明,单卫民,张国平.2型糖尿病患者肾脏早期损伤指标的探讨[J].中国血液流变学杂志,2004,14(3):381-382. 被引量:4
  • 3林善锬.糖尿病肾病[J].中华内科杂志,2005,44(3):229-231. 被引量:117
  • 4董向让,金仲品.糖尿病肾病早期标志物及其临床意义的研究进展[J].中国煤炭工业医学杂志,2005,8(3):205-206. 被引量:8
  • 5Fukami K, Ueda S, Yamagishi S, et al. AGEs activate mesangial TGFbeta- Smad signaling via an angiotensin Ⅱ type Ⅰ receptor interaction.Kidney Int,2004,66(6) :2137 - 2147.
  • 6Kim HW, Kim BC, Song CY, et al. Heterozygous mice for TGF - beta ⅡR gene are resistant to the progression of streptozotocin - induced diabetic nephropathy. Kidney Int,2004,66(5): 1859 - 1865.
  • 7Ellis LR,Warner DR,Greene RM,et al. Interaction of Smads with collagen types Ⅰ、Ⅲ and Ⅴ. Biochem Biophys Res Commun,2003,310(4):1117 - 1123.
  • 8Poncelet AC,Schnaper HW.Sp1 and smad proteins cooperate to mediate transforming growth factor- β1 - inducedα2(Ⅰ)collagen expressiom in human glomerular mesangial cell. J Bio Chem,2001,276(10) :6983 -6992.
  • 9Kanamaru Y,Nakao A,Tanaka Y, et al. Involvement of p300 in TGFbeta/Smad pathway mediated alpha2 (Ⅰ)collagen expression in mouse mesangial cells. Nephron Exp Nephrol,2003,95(1) :36- 42.
  • 10Singh R, Song RH, Alavi N, et al. High glucose decreases matrix metalloproteinase- 2 activity in rat mesangial cells via transforming growth factor- beta(1). Exp Nephrol,2001,9(4) :249 - 257.

共引文献24

同被引文献225

引证文献17

二级引证文献124

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部